NEW YORK (GenomeWeb News) – KeyGene and Floragenex today said that they have agreed to end a legal dispute and have entered into a licensing agreement covering sequence-based genotyping technology.

KeyGene had filed the patent infringement suit against Floragenex last year in the US District Court for the District of Orgeon.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.